article thumbnail

STAT+: Dana-Farber CEO Laurie Glimcher to step down, saying ‘we must look to the next generation’

STAT

Glimcher, chief executive of Dana-Farber Cancer Institute, said she would step down next month, ending an eight-year run capped by her  surprise split  with Dana-Farber’s longtime partner, Brigham and Women’s Hospital, and decision to build a cancer center with Beth Israel Deaconess Medical Center. Benjamin L.

article thumbnail

Empowering Women: 5 Compelling Reasons Women Pursue a Career in Pharmacy

Pharmacy Is Right For Me

Pharmacists can work in a variety of settings, including hospitals, community pharmacies, research laboratories, and government agencies. For example, they can become clinical pharmacists and work in hospitals. They can also become researchers, educators, or consultants.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Teva appoints Eric Hughes as head of R&D and Chief Medical Officer

European Pharmaceutical Review

He then had a one-year stint at Merck Research Laboratories as Director of Clinical Research for Clinical Hepatology before returning to Bristol Myers-Squibb from 2010-2015. Dr Hughes earned his MD and PhD at Yale School of Medicine.

article thumbnail

MSD receives FDA approval for Enflonsia to prevent RSV

Pharmaceutical Technology

MSD research laboratories president Dean Li stated: “Enflonsia provides an important new preventive option to help protect healthy and at-risk infants born during or entering their first RSV season with the same dose regardless of weight. Give your business an edge with our leading industry insights.

FDA 52
article thumbnail

ICR and Royal Marsden NHS Foundation Trust open new integrated pathology unit

Pharmaceutical Technology

The Institute of Cancer Research (ICR), along with its hospital partner The Royal Marsden NHS Foundation Trust, has opened a new joint integrated pathology unit (IPU). The IPU will support clinical trial research and will employ new technology to diagnose cancer in a faster and less expensive way.

article thumbnail

The cluster effect: Connectivity and collaboration in life sciences hubs

Pharmaceutical Technology

Take Charleston, South Carolina, for example, where a growing number of medical device and pharmaceutical manufacturers, research laboratories and service companies have sprung up or settled in recent years. In mid-sized Charleston, connections and collaborations are a constant.

article thumbnail

FDA Approves Clesrovimab-cfor for Prevention of RSV in Infants

Drug Topics

“RSV disease is the leading cause of infant hospitalization in the US and can lead to serious respiratory conditions like bronchiolitis and pneumonia,” Octavio Ramilo, an investigator on the CLEVER and SMART trials., said in a release.

FDA 430